Sterigenics said yesterday it purchased Brazilian sterilization firm Companhia Brasileira de Esterilização.
The Latin American company is the largest sterilization and microbial load reduction firm in the region and the first to use gamma sterilization in Brazil, according to Sterigenics.
“This strategic geographic acquisition demonstrates our commitment to expanding our global footprint in order to meet our customers’ growing needs. Going forward, we will continue investing in the future of Sterigenics and building upon our leadership position,” CEO Michael Mulhern said in a press release.
The acquisition comes on top of the 2014 purchase of Cobalt-60 provider Nordion, as well as Florida-based FTSI and Italy’s Gammarad, Sterigenics said.
“We are very excited to add such a high-quality company as CBE to Sterigenics. CBE brings 3 facilities into our network with a total processing capacity of 12 million cubic feet. With the addition of CBE we now offer 6 locations for processing in Latin America, including sites in Costa Rica and Mexico,” president Philip Macnabb said in a prepared statement.
In May, private equity firm Warburg Pincus acquired a majority stake in Sterigenics, according to GTCR, which bought the company in 2011.
The deal values the company at more than $2 billion, including debt, GTCR said. Other terms of the transaction were not disclosed.